| pubmed-article:14750421 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14750421 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:14750421 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:14750421 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:14750421 | lifeskim:mentions | umls-concept:C0151293 | lld:lifeskim |
| pubmed-article:14750421 | lifeskim:mentions | umls-concept:C0014710 | lld:lifeskim |
| pubmed-article:14750421 | lifeskim:mentions | umls-concept:C0393735 | lld:lifeskim |
| pubmed-article:14750421 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:14750421 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
| pubmed-article:14750421 | lifeskim:mentions | umls-concept:C1280519 | lld:lifeskim |
| pubmed-article:14750421 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:14750421 | pubmed:dateCreated | 2004-1-30 | lld:pubmed |
| pubmed-article:14750421 | pubmed:abstractText | Postulated mechanism of migraine headache is a result of vascular spasm (primary) and dilatation with edema of the perivascular space (secondary). Thus we use drugs not the only during acute phase of headache but in prevention, also. Drugs containing ergotamine are well known and were used for years in the treatment of migraines. In this study we tried to investigate the role of multicomponent drugs containing ergotamine in the treatment of migraine in the adult workers group. | lld:pubmed |
| pubmed-article:14750421 | pubmed:language | pol | lld:pubmed |
| pubmed-article:14750421 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14750421 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14750421 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14750421 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14750421 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14750421 | pubmed:issn | 0033-2240 | lld:pubmed |
| pubmed-article:14750421 | pubmed:author | pubmed-author:Grze?kGrzegor... | lld:pubmed |
| pubmed-article:14750421 | pubmed:author | pubmed-author:Szadujkis-Sza... | lld:pubmed |
| pubmed-article:14750421 | pubmed:author | pubmed-author:WitkowskiWito... | lld:pubmed |
| pubmed-article:14750421 | pubmed:author | pubmed-author:SadochZbignie... | lld:pubmed |
| pubmed-article:14750421 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14750421 | pubmed:volume | 60 | lld:pubmed |
| pubmed-article:14750421 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14750421 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14750421 | pubmed:pagination | 471-4 | lld:pubmed |
| pubmed-article:14750421 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:meshHeading | pubmed-meshheading:14750421... | lld:pubmed |
| pubmed-article:14750421 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14750421 | pubmed:articleTitle | [The effectiveness of ergotamine treatment in chronic headache disorders: a double-blind, randomized, crossover, placebo controlled trial]. | lld:pubmed |
| pubmed-article:14750421 | pubmed:affiliation | Katedra i Zak?ad Farmakologii i Terapii AM ul. M. Sk?odowskiej-Curie 9 85-094 Bydgoszcz. ggrzesk@amb.bydgoszcz.pl | lld:pubmed |
| pubmed-article:14750421 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14750421 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:14750421 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:14750421 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
